Enhancement of tumour growth by lymphoid cells from mice treated with antilymphocyte globulin.
D000818:Animals; D000912:Antibodies, Neoplasm; D000917:Antibody Formation / Q000187:drug effects; D000918:Antibody Specificity; D000951:Antigens, Neoplasm; D000961:Antilymphocyte Serum / Q000494:pharmacology*; D002860:Chromium Radioisotopes; D003165:Complement System Proteins; D003601:Cytotoxicity Tests, Immunologic; D005354:Fibrosarcoma / Q000276:immunology; D006041:Goats / Q000276:immunology; D007111:Immunity, Cellular / Q000187:drug effects; D007112:Immunity, Maternally-Acquired / Q000187:drug effects*; D007116:Immunization, Passive; D007074:Immunoglobulin G; D007165:Immunosuppression Therapy; D017710:Lymphocyte Transfusion; D008297:Male; D012515:Mast-Cell Sarcoma / Q000276:immunology*; D051379:Mice; D008808:Mice, Inbred CBA; D009368:Neoplasm Transplantation; D009374:Neoplasms, Experimental / Q000276:immunology; D011828:Radiation Chimera; D013154:Spleen / Q000166:cytology; D014181:Transplantation Immunology / Q000187:drug effects; D014184:Transplantation, Homologous
D000912:Antibodies, Neoplasm; D000951:Antigens, Neoplasm; D000961:Antilymphocyte Serum; D002860:Chromium Radioisotopes; D007074:Immunoglobulin G; D003165:Complement System Proteins